Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019 Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
News
janssen_latest_logo_on_sign

Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease

April 16, 2019 Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma

Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
News

Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine

April 15, 2019 Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma

Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …
News
about2medical

Medical cannabis: A green light for patients in need?

April 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Feature

Bayer VP elected to two of the firm’s executive committees

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Appointment
manabe

Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Appointment
darren_cline

GW Pharma announce Darren Cline as company’s new Chief Commercial Officer

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
Appointment
merckwindow_web

FDA expands Keytruda label to include stage 3 and 4 non-small cell lung cancer

April 12, 2019 Medical Communications, Research and Development Cancer, MSD, keytruda, lung cancer, non-small cell lung cancer, pharma

MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
News
opioid_pills

Opioid crisis cost US government nearly $38 billion in lost taxes

April 11, 2019 Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue

The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …
News
trafficjamdelhi

Traffic pollution linked to four million childhood asthma cases each year

April 11, 2019 Research and Development Air pollution, NO2, Traffic, asthma, emissions, pollution, public health

Air pollution is linked to four million cases of childhood asthma each year, according to research published in The Lancet …
News
hannah_pender

Living with a rare chromosome disorder

April 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …
Feature

Researchers use CRISPR to reveal gene targets in 30 types of cancer

April 11, 2019 Research and Development Cancer, crispr, drug development, genes, genetics, oncology

Researchers at the Wellcome Sanger Institute and Open Targets have been able to identify thousands of genes which play a …
News
fdaoutsideweb

FDA green lights Amgen and UCB’s Evenity in postmenopausal osteoporosis patients

April 10, 2019 Research and Development, Sales and Marketing Amgen, Evenity, FDA, UCB Pharma, osteoporosis, pharma

The FDA has decided to approve Amgen and UCB Pharma’s Evenity (romosozumab-aqqg) for the treatment of postmenopausal osteoporosis patients at …
News
suboxone_sl_tabs

Indivior shares fall by 70% after allegations of fraud

April 10, 2019 Research and Development Virginia, indivior, opioid crisis, opioids, suboxone

Shares in London-listed Indivior plummeted this morning after US Federal prosecutors said the British drugmaker had deceived doctors as to …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026